Tickerplace logo

Tickerplace

Structure Therapeutics Inc. logo

GPCRStructure Therapeutics Inc.

GPCR Stock Price, Valuation & Chart | Structure Therapeutics Inc.

Compare
$47.800+0.67 (+1.42%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyGPCR intrinsic valueGPCR calculated fair value vs price
OverviewFinancialsDividendsRatios

GPCR Historical price chart

GPCR Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization2.75B
PE Ratio-30.45
EPS-1.57
Trading Volume671.55K
Today's High/Low48.64/46.07
Dividend Yield0.00
52 Week High/Low94.9/18.49
Shares Outstanding57.57M
GPCR Financial Statement
GPCR Analyst ratings
GPCR Analysis & performance metrics

GPCR Company profile

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet…

GPCR Management team

Management
Blai Coll M.D., Ph.D.
Chief Medical Officer
Jun S. YoonCFO
Co- Founder, Chief Financial Officer & Secretary
Yingli Ma Ph.D.CTO
Chief Technology Officer
Bob Gatmaitan
Senior Vice President of People
Raymond C. Stevens Ph.D.CEO
Chief Executive Officer & Director
Tony Peng
Senior Vice President of Legal
Lani Ibarra
Senior Vice President of Clinical Development Operations
Hui Lei Ph.D.
Senior Vice President of Chemistry
Total 8 executives

GPCR Frequently asked questions

What is Structure Therapeutics Inc. (GPCR) Stock Price?

Current stock price of Structure Therapeutics Inc. (GPCR) stock is $47.800. The stock price is +1.42% higher in the session. The intraday range can be seen from this page. Volume of Structure Therapeutics Inc. (GPCR) stock is 671.55K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Structure Therapeutics Inc. (GPCR) stock price going up or down today?

The stock price of Structure Therapeutics Inc. (GPCR) can change with earnings, company news, and overall market sentiment. Structure Therapeutics Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Structure Therapeutics Inc. stock expensive at its current price?

Whether Structure Therapeutics Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GPCR on this page is -30.45. EPS on this page is -1.57. Compare those figures with peers and growth expectations before deciding if the current Structure Therapeutics Inc. price is justified.

How has the stock price of Structure Therapeutics Inc. (GPCR) performed historically?

Historical performance for Structure Therapeutics Inc. (GPCR) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GPCR reacted to past earnings and market events.

Should I buy Structure Therapeutics Inc. (GPCR) stock, at this price?

Buying Structure Therapeutics Inc. (GPCR) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.